SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 198 filers reported holding SANGAMO THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.70 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $71,037 | -39.8% | 40,362 | +7.5% | 0.00% | 0.0% |
| Q4 2022 | $117,904 | -29.0% | 37,549 | +10.8% | 0.00% | -50.0% |
| Q3 2022 | $166,000 | +19.4% | 33,883 | +1.0% | 0.00% | +100.0% |
| Q2 2022 | $139,000 | -28.4% | 33,556 | +0.3% | 0.00% | -50.0% |
| Q1 2022 | $194,000 | -22.1% | 33,471 | +0.7% | 0.00% | 0.0% |
| Q4 2021 | $249,000 | -17.0% | 33,249 | -0.2% | 0.00% | 0.0% |
| Q3 2021 | $300,000 | -24.2% | 33,313 | +0.6% | 0.00% | -33.3% |
| Q2 2021 | $396,000 | -9.8% | 33,099 | -5.4% | 0.00% | -25.0% |
| Q1 2021 | $439,000 | -19.2% | 34,998 | +0.7% | 0.00% | -20.0% |
| Q4 2020 | $543,000 | +59.2% | 34,770 | -3.8% | 0.01% | +66.7% |
| Q3 2020 | $341,000 | +45.7% | 36,132 | +38.1% | 0.00% | 0.0% |
| Q2 2020 | $234,000 | +35.3% | 26,168 | -3.9% | 0.00% | 0.0% |
| Q1 2020 | $173,000 | – | 27,218 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alexandria Capital, LLC | 1,003,725 | $15,663,000 | 1.66% |
| Golden State Equity Partners | 123,817 | $1,932,000 | 1.33% |
| Rhenman & Partners Asset Management AB | 821,888 | $12,826,000 | 1.05% |
| WASATCH ADVISORS LP | 10,072,381 | $157,180,000 | 0.77% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 29,636 | $462,000 | 0.73% |
| Ceeto Capital Group, LLC | 80,000 | $1,248,000 | 0.63% |
| EMC Capital Management | 48,992 | $765,000 | 0.58% |
| Fort Sheridan Advisors LLC | 71,173 | $1,111,000 | 0.54% |
| Vanguard Capital Wealth Advisors | 34,680 | $584,000 | 0.54% |
| Casdin Capital, LLC | 1,080,000 | $16,853,000 | 0.50% |